Atrial fibrillation (AF) is a highly prevalent arrhythmia with pronounced morbidity and
mortality. Genetics analysis has established electrophysiological substrates, which …

Atrial fibrillation (AF) is the most common arrhythmia worldwide and has an enormous
impact on our healthcare system as it is a major contributor of morbidity and mortality …

The pathophysiology of atrial fibrillation (AF) may involve atrial fibrosis/remodeling and
dysfunctional endothelial activities. Despite the currently available treatment approaches …

Atrial fibrillation (AF) is a ubiquitous yet diverse cardiac arrhythmia with an overall
prevalence of 1% in the general population and up to 8% in patients who are N80 years of …

Atrial fibrillation (AF) is the most common sustained arrhythmia, especially in the elderly, and
has a significant genetic component. Recently, several independent investigators have …

Micro ribonucleic acids (miRNAs) are short non-coding RNA molecules responsible for
regulation of gene expression. They are involved in many pathophysiological processes of a …

Atrial fibrillation (AF) is a highly prevalent condition associated with pronounced
cardiovascular-related morbidity, mortality and socioeconomic burden. It accounts for more …

Background: Recent experimental studies have demonstrated that several microRNAs
(miRNAs) expressed in atrial tissue promote a substrate of atrial fibrillation (AF). However …

Atrial fibrillation (AFib), the most prevalent arrhythmia in clinical practice, presents a growing
global health concern, particularly with the aging population, as it is associated with …

Atrial fibrillation (AF), the most common sustained arrhythmia in clinical practice, is an
important contributor to cardiac morbidity and mortality. Pharmacological approaches …